6901.TW DIAMOND BIOFUND INC

Financial Services Asset Management Taiwan Stock Exchange
14.35 TWD
Close of Nov 7, 2026
12.05 22.40
Market cap
TWD 12.2B
P/E
4.3x
P/B
0.99x
ROE
50.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 6901.TW undervalued?

Graham number
Price14.35
Graham value32.97
Discount56.5%

6901.TW trades 56.5% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

DIAMOND BIOFUND INC fundamental analysis

No fundamental analysis for DIAMOND BIOFUND INC yet.

DIAMOND BIOFUND INC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About DIAMOND BIOFUND INC

Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.

Full company profile